跳至主要内容
临床试验/NCT02120261
NCT02120261终止4 期

Using Saline for Myofascial Pain Syndromes (USAMPS)

The University of Texas Health Science Center, Houston2 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2014年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
51
试验地点
2
主要终点
Pain Intensity

研究概览

简要总结

This study involves adult patients diagnosed with Myofascial Pain Syndromes (MPS). The purpose of this research study is to determine if there is a therapeutic difference between trigger point injection (TPI) of normal saline and conventional drug mix (local anesthesic + steroid) in treating MPS.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients diagnosed with MPS of the trapezius, gluteus medius/minimus, iliocostalis thoracis-lumborum, quadratus Lumborum, or paraspinal muscles in the emergency department.

排除标准

  • Patients allergic to lidocaine and/or steroids.
  • Pregnant women.
  • Prisoners.
  • Patients who are cognitively impaired and/or unable to consent for the study.
  • Signs of localized infection or skin breakdown at the injection site.

研究组 & 干预措施

TPI with Normal Saline

Experimental

Trigger point injection (TPI) with 1 mL of normal saline solution. Trigger point injection involves a single injection in the area of maximal tenderness or trigger point. This will be performed by the treating physician under sterile technique with a 25 gauge needle.

干预措施: Normal Saline (Drug)

TPI with Lidocaine & Triamcinolone Acetonide

Active Comparator

Trigger point injection (TPI) with 1 mL of conventional drug mix (lidocaine 1%; 10 mL+ triamcinolone acetonide 40 mg/mL). Trigger point injection involves a single injection in the area of maximal tenderness or trigger point. This will be performed by the treating physician under sterile technique with a 25 gauge needle.

干预措施: Lidocaine Hydrochloride (Drug)

TPI with Lidocaine & Triamcinolone Acetonide

Active Comparator

Trigger point injection (TPI) with 1 mL of conventional drug mix (lidocaine 1%; 10 mL+ triamcinolone acetonide 40 mg/mL). Trigger point injection involves a single injection in the area of maximal tenderness or trigger point. This will be performed by the treating physician under sterile technique with a 25 gauge needle.

干预措施: Triamcinolone acetonide (Drug)

结局指标

主要结局

Pain Intensity

时间窗: 2 weeks

The level of pain intensity is quantified using a standard 0-10 Numerical Rating Scale with 10 being the most severe pain intensity and 0 the absence of pain.

次要结局

  • Duration of Pain Relief(16 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Carlos Roldan

Associate Professor of EMS

The University of Texas Health Science Center, Houston

研究点 (2)

Loading locations...

相似试验